Findings

What do systematic reviews say?

91 questions · 96 findings · 8 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 21 · 21.9%GRADE not reported 14 · 14.6%Very low 29 · 30.2%Low 22 · 22.9%Moderate 10 · 10.4%High 0 · 0%

Chinese herbal medicines vs no intervention

New fractures · patients with osteoporosis

1 finding from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Chinese herbal medicines vs no intervention

Quality of life · patients with osteoporosis

1 finding from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Chinese herbal medicines plus western medicine vs Western medicine

New fractures · patients with osteoporosis

It is very uncertain whether chinese herbal medicines plus western medicine changes new fractures (Yigu capsule plus calcium versus placebo plus calcium) compared with western medicine (very low certainty).

4 findings from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
RR 0.06 [0, 1]
1 study · 140 participants
Very low
Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
RR 0.33 [0.01, 8.02]
1 study · 120 participants
Very low
Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
RR 0.44 [0.13, 1.43]
1 study · 155 participants
Very low

Show 1 more finding

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
RR 0.22 [0.01, 5.34]
1 study · 75 participants
Very low

Chinese herbal medicines plus western medicine vs Western medicine

Quality of life (Bushenhuoxue therapy plus calcium carbonate tablets and alfacalcidol versus calcium carbonate tablets and alfacalcidol) · patients with osteoporosis

1 finding from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Chinese herbal medicines plus western medicine vs Western medicine

Death · patients with osteoporosis

1 finding from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Chinese herbal medicines plus western medicine vs Western medicine

Serious adverse events · patients with osteoporosis

1 finding from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs herbal medicines

Menstrual blood loss: mean loss · heavy menstrual bleeding

2 findings from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 121 participants
Low
Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 45 participants
Very low

Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs herbal medicines

Rates of improvement · heavy menstrual bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs herbal medicines

Adverse events (any) · heavy menstrual bleeding

It is very uncertain whether antifibrinolytics changes adverse events (any) compared with herbal medicines (very low certainty).

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
RR 2.25 [0.74, 6.8]
1 study · 94 participants
Very low

Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs herbal medicines

Thromboembolic events · heavy menstrual bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

STW5 (Iberogast) vs placebo

Global symptoms of dyspepsia · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 814 participants
Very low

Curcuma longa vs placebo

Global symptoms of dyspepsia (responders) · patients with functional dyspepsia

Curcuma longa may leads to higher global symptoms of dyspepsia (responders) compared with placebo (low certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.5 [1.06, 2.11]
1 study · 76 participants
Low

Curcuma longa vs placebo

Adverse events Assessed clinically · patients with functional dyspepsia

Curcuma longa showed no clear difference in adverse events Assessed clinically compared with placebo (moderate certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.26 [0.51, 3.08]
1 study · 89 participants
Moderate

Curcuma longa vs placebo

Quality of life · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 89 participants
Moderate

STW5 (Iberogast) vs placebo

Global symptoms of dyspepsia (responders) · patients with functional dyspepsia

STW5 (Iberogast) showed no clear difference in global symptoms of dyspepsia (responders) compared with placebo (low certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.55 [0.98, 2.47]
2 studies · 324 participants
Low

STW5 (Iberogast) vs placebo

Adverse events Assessed clinically · patients with functional dyspepsia

STW5 (Iberogast) showed no clear difference in adverse events Assessed clinically compared with placebo (low certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 0.92 [0.52, 1.64]
4 studies · 786 participants
Low

STW5 (Iberogast) vs placebo

Quality of life · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 52 participants
Low

Peppermint/caraway oil vs placebo

Global symptoms of dyspepsia · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 210 participants
Moderate

Peppermint/caraway oil vs placebo

Global symptoms of dyspepsia (responders) · patients with functional dyspepsia

Peppermint/caraway oil probably leads to higher global symptoms of dyspepsia (responders) compared with placebo (moderate certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.53 [1.3, 1.81]
3 studies · 305 participants
Moderate

Peppermint/caraway oil vs placebo

Adverse events Assessed clinically · patients with functional dyspepsia

Peppermint/caraway oil showed no clear difference in adverse events Assessed clinically compared with placebo (low certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.56 [0.69, 3.53]
3 studies · 305 participants
Low